C3 AI shares fell 26% on August 11, after the company released preliminary financial results and announced a restructuring of its global sales and services team.

The enterprise AI software company expects fiscal first quarter 2026 revenue between US$70.2 million and US$70.4 million, down from US$87.2 million year-on-year.

It also projected a GAAP operating loss of US$124.7 million to US$124.9 million, deeper than its US$72.6 million loss last year.

CEO Thomas Siebel called the quarter’s sales results “completely unacceptable,” citing the reorganization and his recent health issues as factors.

Siebel has been diagnosed with an autoimmune disease causing significant visual impairment. The board has started a search for his successor.

C3 AI said the restructuring is now complete and will report full first-quarter results on September 3.

🔗 Source: CNBC

🧠 Food for thought

1️⃣ Rapid revenue trajectory reversal signals deeper execution challenges

C3 AI’s preliminary Q1 2026 results represent a dramatic shift from its recent growth pattern, with revenue dropping to $70.2-70.4 million compared to $87.2 million in the same quarter last year.

This 19% year-over-year decline stands in stark contrast to the company’s recent performance, which showed consistent double-digit growth, including 25% revenue growth for FY 2025 and 26% growth in Q3 2025 12.

The company had been successfully diversifying beyond its traditional oil and gas focus, with non-Oil & Gas revenue increasing 48% and operations spanning 19 different industries 1.

The sudden reversal suggests that C3 AI’s growth momentum was more fragile than the consistent quarterly increases indicated, potentially revealing underlying execution vulnerabilities that weren’t apparent during the growth phase.

This demonstrates how quickly enterprise software companies can experience performance volatility, especially when dependent on large deal closures and complex sales cycles.

2️⃣ Leadership dependency remains critical despite partnership-driven sales model

CEO Thomas Siebel’s acknowledgment that his health issues prevented active sales participation highlights a fundamental tension in enterprise AI companies between building scalable sales processes and maintaining founder-led relationships.